Cardiovascular effects of estrogen replacement therapy.
Chae
C U
CU
Harvard Medical School, Division of Preventive Medicine, Brigham and Women's Hospital, Cardiology Division, Massachusetts General Hospital, Boston, USA.
Manson
J E
JE
D002318:Cardiovascular Diseases / Q000503:physiopathology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004727:Endothelium / Q000187:drug effects; D016021:Epidemiologic Studies; D015914:Estrogen Replacement Therapy; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008055:Lipids / Q000097:blood*; D017270:Lipoprotein(a) / Q000097:blood; D017698:Postmenopause / Q000097:blood / Q000187:drug effects*; D011322:Primary Prevention; D011516:Prothrombin / Q000187:drug effects; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D017270:Lipoprotein(a); D020845:Selective Estrogen Receptor Modulators; D014280:Triglycerides; D011516:Prothrombin